Home Stock

Stock Research: Towa Pharmaceutical

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Towa Pharmaceutical

TYO:4553 JP3623150004
81
  • Value
    96
  • Growth
    61
  • Safety
    Safety
    47
  • Combined
    71
  • Sentiment
    67
  • 360° View
    360° View
    81
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Towa Pharmaceutical Co Ltd manufactures and sells pharmaceuticals, primarily generic drugs, and is also involved in the research and outsourced manufacture of active pharmaceutical ingredients and soft capsules, as well as the planning, development, and contract manufacturing of health foods, general foods, and miscellaneous goods. The company is based in Japan. In the last fiscal year, the company had a market cap of $1092 millions, profits of $632 millions, revenue of $1731 millions, and 4788 employees.

more

ANALYSIS: With an Obermatt 360° View of 81 (better than 81% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Towa Pharmaceutical are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Towa Pharmaceutical. The consolidated Value Rank has an attractive rank of 96, which means that the share price of Towa Pharmaceutical is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 96% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 61, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 67. But the company’s financing is risky with a Safety rank of 47. This means 53% of comparable companies have a safer financing structure than Towa Pharmaceutical. ...read more

more
Strongest Rank Leverage
Weakest Rank Value
Country Japan
Industry Pharmaceuticals
Size Large
Website towayakuhin.co.jp
Index
Towa Pharmaceutical stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 7-May-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
96 96 100 99
Growth
61 26 63 79
Safety
Safety
47 47 37 63
Sentiment
67 68 45 37
360° View
360° View
81 72 73 91
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
55 60 63 46
Opinions Change
50 50 79 50
Pro Holdings
n/a 66 48 53
Market Pulse
36 52 11 28
Sentiment
67 68 45 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
96 96 100 99
Growth
61 26 63 79
Safety Safety
47 47 37 63
Combined
71 67 88 98
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
92 97 97 100
Price vs. Earnings (P/E)
86 97 90 100
Price vs. Book (P/B)
85 90 89 82
Dividend Yield
77 58 76 81
Value
96 96 100 99
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
40 45 46 72
Profit Growth
53 30 96 55
Capital Growth
36 4 7 5
Stock Returns
87 62 63 100
Growth
61 26 63 79
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
5 3 1 10
Refinancing
88 98 99 87
Liquidity
61 37 32 70
Safety Safety
47 47 37 63

Similar Stocks

Discover high‑ranked alternatives to Towa Pharmaceutical and broaden your portfolio horizons.

Inpex

TYO:1605
Country: Japan
Industry: Oil & Gas Production
Size: X-Large
Full Stock Analysis

Shionogi

TYO:4507
Country: Japan
Industry: Pharmaceuticals
Size: X-Large
Full Stock Analysis

NGK Insulators

TYO:5333
Country: Japan
Industry: Industrial Machinery
Size: X-Large
Full Stock Analysis

Sekisui Chemicalical

TYO:4204
Country: Japan
Industry: Industrial Conglomerates
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This is a high-quality, high-growth stock with positive sentiment. However, the financing is on the riskier side. It is best for a growth-focused investor willing to accept higher financial risk for potentially higher shareholder returns.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews